Guiding Preventive Care Strategies for Patients With Atherosclerotic Plaque on Coronary CTA: Primary Outcomes of the DECIDE Registry - PubMed
7 hours ago
- #Coronary CTA
- #Atherosclerotic Plaque
- #Preventive Care
- The DECIDE registry studied the impact of AI-enabled coronary plaque analysis (AI-CPA) on preventive care strategies for patients with atherosclerotic plaque detected via coronary CTA.
- Changes in management occurred in 51.3% of participants after AI-CPA findings were made available, with more extensive plaque correlating with higher intervention rates (up to 67.8%).
- Intensification of medical therapy was the most common management change, observed in 35.6% of participants.
- Patients with management changes experienced greater reductions in LDL cholesterol (-11 mg/dL) compared to those without changes (1 mg/dL).
- The study concludes that AI-CPA is associated with significant preventive management changes, particularly in patients with more extensive plaque, warranting further randomized trials.